Trulieve Cannabis Corp. (TRLV) financials: revenue, earnings and cash flow
Fiscal 2019–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Trulieve Cannabis’s revenue went from $253M in fiscal 2019 to $1.2B in fiscal 2025, growth of about 29.3% a year.
Net income in fiscal 2025 was -$116M, a net margin of -9.9%; the best year in this period was 2020 with $63M.
Over the twelve months to September 30, 2026, revenue was $1.1B and net income -$446M.
Free cash flow was $229M in fiscal 2025 and positive in 3 of the 7 years shown.
The diluted share count rose 66% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.2B | $1.2B | $1.1B | $1.2B | $932M | $522M | $253M |
| Gross profit | $656M | $711M | $716M | $589M | $689M | $567M | $386M | $192M |
| Operating income | -$277M | $143M | $98M | -$222M | $50M | $204M | $218M | $113M |
| Net income | -$446M | -$116M | -$155M | -$527M | -$253M | $17M | $63M | $53M |
| EPS (diluted) | $-2.31 | $-0.58 | $-0.79 | $-2.28 | $-0.95 | $0.21 | $0.53 | $0.46 |
| R&D | — | — | — | — | — | — | — | — |
| Revenue growth | — | −0.4% | +5.1% | −7.3% | +30.7% | +78.7% | +106.3% | — |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $242M | $273M | $271M | $202M | $23M | $13M | $100M | $19M |
| Capital spending | -$54M | -$44M | -$123M | -$40M | -$165M | -$276M | -$100M | -$72M |
| Free cash flow | $188M | $229M | $149M | $162M | -$142M | -$263M | -$298000 | -$53M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | — | — | — | — | — | — | — | — |
| Stock-based pay | $21M | $20M | $20M | $11M | $18M | $9M | $3M | — |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash | — | $256M | $299M | $201M | $207M | $227M | $147M | $92M |
| Debt | — | $258M | $494M | $466M | $654M | $595M | $37M | — |
| Equity | — | $1.1B | $1.2B | $1.4B | $1.9B | $2.1B | $448M | $133M |
| Total assets | — | $2.7B | $2.9B | $2.7B | $3.4B | $3.4B | $810M | — |
| Shares (diluted) | 201M | 191M | 190M | 189M | 188M | 147M | 118M | 115M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 60.6% | 60.2% | 60.3% | 52.1% | 56.6% | 60.8% | 74.1% | 75.9% |
| Operating margin | -25.6% | 12.2% | 8.2% | -19.6% | 4.1% | 21.9% | 41.9% | 44.8% |
| Net margin | -41.2% | -9.8% | -13.1% | -46.7% | -20.8% | 1.9% | 12.1% | 21.0% |
| FCF margin | 17.4% | 19.4% | 12.6% | 14.3% | -11.6% | -28.2% | -0.1% | -20.9% |
| ROIC | — | 8.1% | 4.4% | -9.3% | 1.5% | 5.9% | 35.5% | 43.6% |
| ROE | — | -10.2% | -12.4% | -37.4% | -13.1% | 0.8% | 14.1% | 40.0% |
Frequently asked questions
What is Trulieve Cannabis’s annual revenue?
$1.2B in fiscal 2025 and $1.1B over the twelve months to September 30, 2026.
How much profit does Trulieve Cannabis make?
Net income was -$116M in fiscal 2025 (net margin -9.9%).
Is Trulieve Cannabis’s revenue growing?
No: revenue fell 0.4% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.